New program aims to give veterans with advanced cancer a stronger voice in their End-of-Life care

NCT ID NCT07690904

First seen Jul 08, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests a program that pairs veterans with advanced cancer with a lay health worker who helps them discuss their goals and preferences for care with their doctors. The goal is to increase the number of veterans who have these important conversations and document their wishes, reducing unwanted intensive treatments at the end of life. The trial involves 200 veterans across 7 VA sites and compares the program to usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
lay health worker-led educational and support intervention
What this could lead to
If successful, this approach could help more veterans with advanced cancer have important conversations about their care preferences, potentially reducing unwanted aggressive treatments at the end of life.
What could go wrong
The trial is relatively small (200 participants) and tests a behavioral intervention, so results may not apply broadly. It also relies on self-reported outcomes, which can be subjective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • VA Palo Alto Health Care System, Palo Alto, CA

    Palo Alto, California, 94304-1207, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.